Sanofi Edges Higher As Immunology Powerhouse, Dupixent, Wallops Forecasts

Sanofi Stock Creeps Higher On 'Essentially In Line' Guidance For 2026 | Investor's Business DailyBREAKING: [Rare Earths Stocks Skid On Policy Shift]---Sanofi (SNY) stock edged higher early Thursday after the French pharma giant reported adjusted earnings of 91 cents per share on $13.5 billion in fourth-quarter sales. Analysts polled by FactSet expected Sanofi to earn 84 cents a share and report $13.57 billion in sales. During the year-ago period, Sanofi earned 68 cents per share on $11.89 billion in sales. ...